| Registry | NCT04343898, acronym STOP-COVID |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 5154 (Actual) |
| Sponsor | Brigham and Women's Hospital (Other); collaborators: Icahn School of Medicine at Mount Sinai, Montefiore Medical Center, Baylor College of Medicine, Baylor Health Care System, Beth Israel Deaconess Medical Center, University of Colorado, Denver, Cook County Hospital, The Cooper Health System, Duke University, Georgetown University, Hackensack mountainside hospital, Hackensack Meridian Health, Indiana University Health Methodist Hospital, Johns Hopkins University, Loma Linda University, Mayo Clinic, Medical College of Wisconsin, Northwestern University, Weill Medical College of Cornell University, NYU Langone Health, Ochsner Health System, Oregon Health and Science University, Renown Health, Rush University Medical Center, New Jersey Medical School, Rutgers Robert Wood Johnson Medical School, Stanford University, Temple University, Tufts Medical Center, Tulane University, University of California, Davis, University of California, Los Angeles, University of California, San Diego, University of California, San Francisco, University of North Carolina, Chapel Hill, University Hospitals Cleveland Medical Center, University Medical Center of Southern Nevada, University of Alabama at Birmingham, University of Chicago, University of Florida, University of Illinois at Chicago, University of Kentucky, University of Miami, University of Michigan, University of Oklahoma, University of Pennsylvania, University of Pittsburgh Medical Center, University of Tennessee, University of Washington, University of Texas, Southwestern Medical Center at Dallas, Yale University |
| Conditions | Coronavirus Infection |
| Interventions | No intervention (Other) |
| Dates | start 2020-04-01, primary completion 2020-08-01, completion 2023-07-01, first posted 2020-04-13, last updated 2023-08-09 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Coronavirus Infection All trials of No intervention
Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.
The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.
Sex: All, ages: 18 Years to any
Inclusion Criteria (each of the following): 1. Adults (aged ≥18 years) 2. Laboratory-confirmed diagnosis of COVID-19 3. Hospitalized in the ICU for illness related to COVID-19 Exclusion Criteria: -None
| Facility | City | Country | Status |
|---|---|---|---|
| Brigham and Women's Hospital | Boston, Massachusetts | United States |